You receive a free virtual consultation to ensure the medication is safe and appropriate for your individual health profile
Starting at a low dose and increasing gradually helps minimize initial side effects
Milesi MA, Lacan D, Brosse H, Desor D, Notin C
short sequential cohort about -4.7% during the initial 2.5 mg phase and -12.7% by the end of the 5 mg phase (Barrea EXCLI Journal 2026)
When combined with Ipamorelin, which is known for its ability to stimulate GH release without increasing cortisol, the Ipamorelin CJC-1295 No DAC Blend offers a prolonged GH secretion profile
They come primarily from industry-sponsored cosmetic studies rather than large, independent, placebo-controlled dermatological trials